Agent for inducing regression of triglyceride deposit atherosclerosis
AssigneeOsaka University
InventorKen-ichi Hirano
Life of this patent
Estimating the term…
Abstract
The present invention provides an agent for inducing regression of triglyceride (TG) deposit atherosclerosis, which agent comprises tricaprin/trisdecanoin as an active ingredient, an agent for improving blood flow in a patient with TG deposit atherosclerosis, which agent comprises tricaprin/trisdecanoin as an active ingredient, and a pharmaceutical or food or drink product comprising the agent for inducing regression of TG deposit atherosclerosis or the agent for improving blood flow.
Claims8
A method for inducing regression of triglyceride deposit atherosclerosis, comprising administering tricaprin/trisdecanoin to a patient with triglyceride deposit atherosclerosis, wherein the regression of triglyceride deposit atherosclerosis is accompanied by a reduction of 14% or greater in lipid accumulation and an increase of 17% or greater in vascular lumen in coronary arteries with triglyceride deposit atherosclerosis.
A method for improving blood flow, comprising administering tricaprin/trisdecanoin to a patient with triglyceride deposit atherosclerosis, wherein the improvement in blood flow is accompanied by a reduction of 14% or greater in lipid accumulation and an increase of 17% or greater in vascular lumen in coronary arteries with triglyceride deposit atherosclerosis.
Dependencies are inferred from the claim text.